Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

0.52
EUR
0.00
(0.00%)
-0.64EPS
262.87MMarket Cap
Dec 18Next Earn

Latest Stock Split

Mar 14, 2024

1:20

For every 20 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Mar 14, 2024
    Before—
    Split ratio1:20
    After—
    Reverse
  2. Mar 18, 2019
    Before—
    Split ratio1:8
    After—
    Reverse

About Outlook Therapeutics, Inc. stock splits

Outlook Therapeutics, Inc. (GETTEX:41O) operates in the Pharmaceuticals: major industry.

Outlook Therapeutics, Inc. company overview

When did Outlook Therapeutics, Inc. stock split?

Outlook Therapeutics, Inc.'s most recent stock split was on March 14, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.

What is Outlook Therapeutics, Inc.'s stock split history?

Outlook Therapeutics, Inc. (GETTEX:41O) has split its stock 2 times: a 1-for-8 reverse split on March 18, 2019 and a 1-for-20 reverse split on March 14, 2024.

How many times has Outlook Therapeutics, Inc. stock split?

Outlook Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between March 18, 2019 and March 14, 2024.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Outlook Therapeutics, Inc.'s 1-for-20 reverse split on March 14, 2024, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Outlook Therapeutics, Inc. split its stock again?

Outlook Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on March 14, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:41O split will appear on this page.